Major change for rare disease treatments on way, signals MHRA
Our October 2025 Board meeting took place at a time of significant reflection for the legal sector. The findings of an independent review into the Solicitors Regulation Authority’s (SRA’s) regulation of SSB Group...
Rare therapies and UK regulatory considerations
Defence Housing Strategy: A £9bn âgenerational renewal' for forces family housing and 100,000 new homes on MOD land to drive growth